ClemeƱa, Ruvelyn .

HRN: 27-99-28  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/24/2026
CEFUROXIME 500MG (TAB)
04/26/2026
05/03/2026
ORAL
500mg
BID
S/P Pelvic Laparotomy
Pending Pharmacy Acceptance 

Indication:  Prophylaxis    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: